Literature DB >> 15665029

Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysis.

Casper P Bots1, Henk S Brand, Enno C I Veerman, Johanna C Korevaar, Marianne Valentijn-Benz, Pieter D Bezemer, Robert M Valentijn, Pieter F Vos, Joost A Bijlsma, Piet M ter Wee, Barbara M Van Amerongen, Arie V Nieuw Amerongen.   

Abstract

BACKGROUND: Most patients on haemodialysis (HD) have to maintain a fluid-restricted diet to prevent a high interdialytic weight gain (IWG). The prevalence of xerostomia (the feeling of a dry mouth) is higher in HD patients than in controls. Recently, we demonstrated that xerostomia and thirst were positively correlated with IWG in HD patients. Thus, this may play a role as a stimulus for fluid intake between dialysis sessions. The aim of the present study was to investigate the effect of chewing gum or a saliva substitute on xerostomia, thirst and IWG.
METHODS: This study was a randomized two-treatment crossover design with repeated measures. After the use of chewing gum or saliva substitute for 2 weeks, a wash-out period of 2 weeks was introduced and hereafter the other regimen was carried out. Xerostomia and thirst were assessed by validated questionnaires as xerostomia inventory (XI) and dialysis thirst inventory (DTI), at baseline and after each treatment period, as were IWG and salivary flow rates.
RESULTS: Sixty-five HD patients (42 men, 54.6+/-14.1 years; 23 women, 54.7+/-16.3 years) participated in this study. Chewing gum decreased XI from 29.9+/-9.5 to 28.1+/-9.1 (P<0.05). Chewing gum as well as a saliva substitute reduced DTI significantly (P<0.05), but no differences occurred for the average IWG or salivary flow rates.
CONCLUSIONS: The use of chewing gum and, to a lesser extent, a saliva substitute may alleviate thirst and xerostomia in some HD patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665029     DOI: 10.1093/ndt/gfh675

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  13 in total

1.  Effects of A Novel Disc Formulation on Dry Mouth Symptoms and Enamel Remineralization in Patients With Hyposalivation: An In Vivo Study.

Authors:  Jessica Ho; Miracle Vania Firmalino; Afarin Golabgir Anbarani; Thair Takesh; Joel Epstein; Petra Wilder-Smith
Journal:  Dentistry (Sunnyvale)       Date:  2017-02-13

2.  Shortening the xerostomia inventory.

Authors:  William Murray Thomson; Gert-Jan van der Putten; Cees de Baat; Kazunori Ikebe; Ken-ichi Matsuda; Kaori Enoki; Matthew S Hopcraft; Guo Y Ling
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-07-16

Review 3.  Symptom identification in the chronically critically ill.

Authors:  Grace B Campbell; Mary Beth Happ
Journal:  AACN Adv Crit Care       Date:  2010 Jan-Mar

4.  Home-delivered meals as an adjuvant to improve volume overload and clinical outcomes in hemodialysis.

Authors:  Luis M Perez; Annabel Biruete; Kenneth R Wilund
Journal:  Clin Kidney J       Date:  2022-04-19

Review 5.  Hunger and thirst: issues in measurement and prediction of eating and drinking.

Authors:  Richard D Mattes
Journal:  Physiol Behav       Date:  2010-01-11

6.  Determinants of thirst distress in patients on hemodialysis.

Authors:  Belgüzar Kara
Journal:  Int Urol Nephrol       Date:  2016-05-23       Impact factor: 2.370

Review 7.  Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.

Authors:  Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Magí Farré
Journal:  Int J Med Sci       Date:  2015-09-22       Impact factor: 3.738

Review 8.  Patient-Reported Outcome Instruments for Physical Symptoms Among Patients Receiving Maintenance Dialysis: A Systematic Review.

Authors:  Jennifer E Flythe; Jill D Powell; Caroline J Poulton; Katherine D Westreich; Lara Handler; Bryce B Reeve; Timothy S Carey
Journal:  Am J Kidney Dis       Date:  2015-07-23       Impact factor: 8.860

9.  Effect of chitosan chewing gum on reducing serum phosphorus in hemodialysis patients: a multi-center, randomized, double-blind, placebo-controlled trial.

Authors:  Tadao Akizawa; Yoshinari Tsuruta; Yoichi Okada; Yoshihiro Miyauchi; Akio Suda; Hiroshi Kasahara; Nobuhiro Sasaki; Yoshitaka Maeda; Takako Suzuki; Noriaki Matsui; Jun Niwayama; Toshiaki Suzuki; Hideaki Hara; Yasushi Asano; Sadao Komemushi; Masafumi Fukagawa
Journal:  BMC Nephrol       Date:  2014-06-25       Impact factor: 2.388

10.  Carious status and supragingival plaque microbiota in hemodialysis patients.

Authors:  Qi Yue; Fei-Ting Yin; Qian Zhang; Chao Yuan; Mei-Yan Ye; Xiao-Ling Wang; Ji-Jun Li; Ye-Hua Gan
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.